Compositions of aminosugars, glycosaminoglycans and s-adenosylmethionine for the treatment or repair of connective tissue in mammals
CA 2539696 A1 · Owner: Henderson, Robert W. · Inventors: Henderson, Todd; Henderson, Robert W.; Hammad, Tarek
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A composition for the protection, treatment and repair and for reducing the inflammation of, connective tissue in mammals and a method for the protection treatment of , connective tissue in, mammals by the administration of the composition. The composition includes at least two, compounds selected from S-Adenosylmethionine (SAM) an aminosugar selected , from the group consisting of glucosamine, glucosamine salts glucosamine hydrochloride, galactosamine N-, acetylglucosamine, and fragments, mixtures or salts thereof and a , glycosaminoglycan or, glycosaminoglycan-like compound selected from the group consisting of chondroitin, chondroitin salts, hyaluronic acid glucaronic acid, iduronic …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 17, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 17, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 17, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.